Document is current
Any future updates will be listed below
-
Authors
Appolinario, Jose C. http://orcid.org/0000-0002-6089-4400
Sichieri, Rosely http://orcid.org/0000-0001-5286-5354
Lopes, Claudia S. http://orcid.org/0000-0002-0401-689X
Moraes, Carlos E. http://orcid.org/0000-0002-8724-8652
da Veiga, Gloria V.
Freitas, Silvia
Nunes, Maria A. A. http://orcid.org/0000-0002-9077-7774
Wang, Yuan-Pang http://orcid.org/0000-0001-7076-8312
Hay, Phillipa http://orcid.org/0000-0003-0296-6856
-
Funding
Funding for this research was provided by:
Takeda Pharmaceutical Company
- License Information
-
More Information
Article History
Received: 30 May 2021
Accepted: 6 January 2022
First Online: 19 January 2022
Declarations
:
: Jose C. Appolinario has received research grants, consultancy fees and advisory board fees from Takeda Pharmaceuticals. He receives/has received royalties/honoraria from Artmed Panamericana Editora. He also received a research grant from the Brazilian National Research Council (CNPq). Phillipa Hay has received sessional fees and lecture fees from the Australian Medical Council, Therapeutic Guidelines publication and New South Wales Institute of Psychiatry and royalties from Hogrefe and Huber, McGraw Hill Education and Blackwell Scientific Publications and she has received research support from CAPES, NHMRC and ARC. She is Chair of the National Eating Disorders Collaboration in Australia (2019-). She is a consultant to Takeda Pharmaceuticals. The other authors have no conflicts of interest to declare<b>.</b>
